Livongo Health gets $5M from Humana

Livongo Health

Livongo Health has scored fresh capital from Humana, and has completed its Series C round that now totals $49.5 million. In other words, the insurance giant invested $5 million with plans to offer Livongo’s chronic condition management platform to more of its clients.

“We’re proud to be a strategic investor in Livongo to support their continued efforts,” Busy Burr, Vice President of Innovation and Head of Humana Health Ventures, said in a statement. “We look forward to together making living with chronic conditions easier for everyone, beginning with our members with diabetes.”

In the first phase of the partnership, Humana has made Livongo’s diabetes management tools available to a select group of its members, with the idea to bring the service to more people in the near future.

“By combining the capabilities of large enterprises like Humana with nimble start-ups like Livongo Health, we’re able to create high-tech, high-touch solutions that will better support individuals while leveraging and learning from Humana’s research and benefiting from their distribution to transform our healthcare system,” Glen Tullman, CEO of Livongo Health, said in a statement.

Livongo Health’s solution combines technology and coaching in a streamlined, consumer-directed experience. Included in the deal are a cellular, two-way interactive glucose meter that transmits data and messaging real-time, a smart cloud that provides personalized analytics and insights, and a human touch from certified diabetes educators linked to the patient’s care team including family, friends and medical professionals.